University of Waterloo Purchases Veeco MBE System
News Apr 25, 2013
Veeco Instruments Inc. has announced that the University of Waterloo, located at the heart of Canada’s technology hub, has purchased a GEN10® Molecular Beam Epitaxy system for its recently opened Quantum-Nano Centre (QNC) hosting the Waterloo Institute for Nanotechnology (WIN) and the Institute for Quantum Computing (IQC).
The system will be installed in the new MBE laboratory being established by Professor Zbig Wasilewski, Endowed Nanotechnology Chair at WIN.
According to Professor Wasilewski, “MBE technology is rich in its application across several fields of study that we are focusing on here at WIN and IQC. After thorough evaluation, we thought the GEN10 was the best choice due to its flexible cluster architecture, system design details, full automation and relatively small footprint. It ideally fits our needs across many research frontiers. Also, given the importance of effusion cells to our research, we thought Veeco would be a great choice given their expertise and our history with their cells.”
Jim Northup, Vice President, General Manager of Veeco’s MBE Operations, commented, “Our team is very excited that the University of Waterloo has selected the GEN10 as its first piece of equipment to be installed at the new Quantum-Nano Center. It’s a great example of how Veeco’s state of the art MBE technology continues to remain at the forefront of broad based research around the world.”
The Mike & Ophelia Lazaridis Quantum-Nano Centre opened in the fall of 2012.
The QNC is dedicated to allowing faculty and students to pursue quantum information and nanotechnology research at the highest level.
Shared between the Institute of Quantum Computing and the Waterloo Institute of Nanotechnology, the building fosters cross-disciplinary collaboration in its many common areas, lounges and meeting rooms.
Combating Cancer by Targeting Sugar ReceptorsNews
Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Prof. Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018